Advancing Thin Film Implants for Spinal Cord Stimulation—Innovations in Electrode Design and Methodology from Industry Perspectives

The field of spinal cord stimulation (SCS) has not seen significant advancements in many years: electrode design and implantation methodologies have remained the same for a couple of decades. At NeuroOne, we are exploring a novel approach to developing thin film leads for SCS applications while integrating user feedback and creating a path to market. The proposed technology aims to revolutionize SCS therapy by introducing new electrode materials and designs without compromising user familiarity and comfort during the implantation process.<br/>Traditional SCS electrodes typically use bulky materials and designs, which can limit flexibility and versatility of the implant location. In contrast, thin film technology offers advantages such as reduced size, increased biostability, and potentially new treatment options for the patients. Our approach focuses on leveraging these benefits through the development of advanced thin film electrodes that are not only smaller and more flexible but also capable of delivering precise stimulation patterns tailored to individual patient needs.<br/>Key challenges addressed in this innovation include maintaining or improving upon the durability and reliability of current electrode designs, ensuring compatibility with existing SCS systems, minimizing disruption to established supply chains, and integrating user feedback. User feedback plays a crucial role throughout the development process, guiding the design iterations to ensure that the new technology meets the logistical and functional expectations of healthcare providers and patients.<br/>Furthermore, the methodology for implanting these new electrodes will be discussed, emphasizing a seamless transition for clinicians accustomed to current implantation techniques. By aligning with familiar procedural protocols and leveraging advancements in surgical tools and techniques, the goal is to streamline the adoption of this new technology into clinical practice.<br/>The integration of user feedback and supply chain considerations into the development of thin film electrodes for SCS represents a paradigm shift in medical device innovation. Here, the goal is to highlight the collaborative efforts between industry stakeholders, researchers, and clinicians to drive advancements that not only enhance therapeutic outcomes but also improve the overall user experience and accessibility of SCS therapy.